- Home
- GRRR vs DARE Comparison
GRRR vs DARE Comparison
Compare GRRR & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRRR
- DARE
- Stock Information
- Founded
- GRRR 2001
- DARE N/A
- Country
- GRRR United Kingdom
- DARE United States
- Employees
- GRRR N/A
- DARE N/A
- Industry
- GRRR Computer Software: Prepackaged Software
- DARE Biotechnology: Pharmaceutical Preparations
- Sector
- GRRR Technology
- DARE Health Care
- Exchange
- GRRR Nasdaq
- DARE Nasdaq
- Market Cap
- GRRR 28.7M
- DARE 31.9M
- IPO Year
- GRRR N/A
- DARE N/A
- Fundamental
- Price
- GRRR $4.32
- DARE $3.77
- Analyst Decision
- GRRR Buy
- DARE Strong Buy
- Analyst Count
- GRRR 1
- DARE 4
- Target Price
- GRRR $9.00
- DARE $20.33
- AVG Volume (30 Days)
- GRRR 586.8K
- DARE 60.6K
- Earning Date
- GRRR 11-22-2024
- DARE 11-14-2024
- Dividend Yield
- GRRR N/A
- DARE N/A
- EPS Growth
- GRRR N/A
- DARE N/A
- EPS
- GRRR 2.28
- DARE N/A
- Revenue
- GRRR $78,940,347.00
- DARE $2,839,625.00
- Revenue This Year
- GRRR $15.59
- DARE $388.48
- Revenue Next Year
- GRRR $20.59
- DARE $67.37
- P/E Ratio
- GRRR $1.89
- DARE N/A
- Revenue Growth
- GRRR 424.97
- DARE N/A
- 52 Week Low
- GRRR $2.09
- DARE $3.05
- 52 Week High
- GRRR $13.00
- DARE $7.56
- Technical
- Relative Strength Index (RSI)
- GRRR 53.71
- DARE 49.53
- Support Level
- GRRR $4.16
- DARE $3.42
- Resistance Level
- GRRR $4.76
- DARE $4.22
- Average True Range (ATR)
- GRRR 0.32
- DARE 0.30
- MACD
- GRRR -0.02
- DARE 0.00
- Stochastic Oscillator
- GRRR 48.75
- DARE 35.59
About GRRR Gorilla Technology Group Inc. Ordinary shares
Gorilla Technology Group Inc is primarily engaged in providing information, software, and data processing services. It is a provider of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology (OT) security solutions and services. Its reportable segments are video IoT and security convergence and Other segments.
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.